|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 474.29 USD | -1.68% |
|
-5.63% | -2.64% |
EPS & Dividend: United Therapeutics Corporation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 11.54 | 10.06 | 15 | 19.81 | 24.64 | 27.09 | 28.6 | 30.77 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 151.79 | 216.08 | 278.09 | 219.89 | 352.84 | 482.39 | 482.39 | 482.39 |
| Nbr of stocks (in thousands) | 44,441 | 45,037 | 45,577 | 46,994 | 44,645 | 43,057 | 43,057 | - |
| Announcement Date | 24/02/21 | 24/02/22 | 22/02/23 | 21/02/24 | 26/02/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: United Therapeutics Corporation
| 24/02/2026 | Q4 2025 Earnings Release (Projected) |
| 05/05/2026 | Q1 2026 Earnings Release (Projected) |
| 04/08/2026 | Q2 2026 Earnings Release (Projected) |
| 03/11/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | 17.8x | 2.57x | 5.52x | |
| 0.55% | 0.61% | 47.23x | 36.06x | 15.63x | |
| 2.46% | 2.53% | 20.37x | 6.45x | 5.66x | |
| 2.97% | 3.1% | 74.56x | 696.66x | 7.3x | |
| 2.88% | 2.94% | 19.92x | 7.09x | 4.98x | |
| 1.7% | 1.79% | 28.73x | 6.46x | 5.4x | |
| 2.96% | 3.01% | 14.03x | 5.02x | 4.59x | |
| 2.86% | 2.97% | 20.04x | 6.18x | 5.3x | |
| 3.07% | 3.01% | 16.44x | 8.93x | 5.81x | |
| 2.94% | 3.08% | 25.74x | 19.37x | 6.05x | |
| Average | 2.24% | 2.3% | 28.49x | 79.48x | 6.62x | |
| Weighted average by Cap. | 2.1% | 2.17% | 33.81x | 91.37x | 8.40x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition